| Development and validation of a predictive model for chemotherapy-associated thrombosis AA Khorana, NM Kuderer, E Culakova, GH Lyman, CW Francis Blood, The Journal of the American Society of Hematology 111 (10), 4902-4907, 2008 | 2126 | 2008 |
| Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy AA Khorana, CW Francis, E Culakova, NM Kuderer, GH Lyman Journal of Thrombosis and Haemostasis 5 (3), 632-634, 2007 | 1724 | 2007 |
| American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer GH Lyman, AA Khorana, A Falanga, D Clarke-Pearson, C Flowers, ... Journal of clinical oncology 25 (34), 5490-5505, 2007 | 1290 | 2007 |
| Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update NS Key, AA Khorana, NM Kuderer, K Bohlke, AYY Lee, JI Arcelus, ... Journal of Clinical Oncology 38 (5), 496-520, 2020 | 1103 | 2020 |
| Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology SG Mohile, W Dale, MR Somerfield, MA Schonberg, CM Boyd, ... Journal of Clinical Oncology 36 (22), 2326, 2018 | 1063 | 2018 |
| Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients AA Khorana, CW Francis, E Culakova, NM Kuderer, GH Lyman Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 987 | 2007 |
| Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update GH Lyman, AA Khorana, NM Kuderer, AY Lee, JI Arcelus, EP Balaban, ... Journal of Clinical Oncology 31 (17), 2189-2204, 2013 | 947 | 2013 |
| Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014 GH Lyman, K Bohlke, AA Khorana, NM Kuderer, AY Lee, JI Arcelus, ... Journal of Clinical Oncology 33 (6), 654, 2015 | 868 | 2015 |
| Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014 GH Lyman, K Bohlke, AA Khorana, NM Kuderer, AY Lee, JI Arcelus, ... Journal of Clinical Oncology 33 (6), 654, 2015 | 868 | 2015 |
| Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group–directed intergroup trial … PA Philip, J Benedetti, CL Corless, R Wong, EM O'Reilly, PJ Flynn, ... Journal of clinical oncology 28 (22), 3605, 2010 | 712 | 2010 |
| Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study AA Khorana, CW Francis, E Culakova, GH Lyman Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 674 | 2005 |
| International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, P Debourdeau, M Beckers, C Baglin, RM Bauersachs, B Brenner, ... Journal of Thrombosis and Haemostasis 11 (1), 56-70, 2013 | 662 | 2013 |
| Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial AYY Lee, PW Kamphuisen, G Meyer, R Bauersachs, MS Janas, ... Jama 314 (7), 677-686, 2015 | 649 | 2015 |
| Assessing risk of venous thromboembolism in the patient with cancer AA Khorana, GC Connolly Journal of Clinical Oncology 27 (29), 4839, 2009 | 635 | 2009 |
| Thromboembolism in hospitalized neutropenic cancer patients AA Khorana, CW Francis, E Culakova, RI Fisher, NM Kuderer, GH Lyman Journal of Clinical Oncology 24 (3), 484-490, 2006 | 604 | 2006 |
| Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer AA Khorana, GA Soff, AK Kakkar, S Vadhan-Raj, H Riess, T Wun, ... New England Journal of Medicine 380 (8), 720-728, 2019 | 576 | 2019 |
| Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United States AA Khorana, M Dalal, J Lin, GC Connolly Cancer 119 (3), 648-655, 2013 | 497 | 2013 |
| Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer AA Khorana, SA Ahrendt, CK Ryan, CW Francis, RH Hruban, YC Hu, ... Clinical cancer research 13 (10), 2870-2875, 2007 | 464 | 2007 |
| Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer AA Khorana, CW Francis, N Blumberg, E Culakova, MA Refaai, ... Archives of internal medicine 168 (21), 2377-2381, 2008 | 458 | 2008 |
| Venous thromboembolism and prognosis in cancer AA Khorana Thrombosis research 125 (6), 490-493, 2010 | 428 | 2010 |
Gary LymanFred Hutchinson Cancer Research Center and University of Washington在 fhcrc.org 的电子邮件经过验证
